5-异丙氧基-2-氨基-苯甲酸 | 68701-42-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-异丙氧基-2-氨基-苯甲酸
• 中文别名: 2-氨基-5-(丙-2-基氧基)苯甲酸
• 英文名称: 5-isopropoxy-2-amino-benzoic acid
• 英文别名: 2-amino-5-(1-methylethoxy)benzoic acid；5-isopropoxy-anthranilic acid；5-isopropoxy-2-aminobenzoic acid；5-isopropoxyanthranilic acid；2-Amino-5-isopropoxybenzoic acid；2-amino-5-propan-2-yloxybenzoic acid
• CAS: 68701-42-8
• 化学式: C₁₀H₁₃NO₃
• 分子量: 195.218
• InChiKey: LKWPCZDBLQUFJQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  72.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  5-异丙氧基-2-氨基-苯甲酸 在 sodium hydroxide 、 potassium iodide 作用下， 以 various solvent(s) 为溶剂， 反应 24.0h， 生成 2-isopropoxy-11-oxo-11H-pyrido[2,1-b]quinazoline-8-carboxylic acid (2-diethylaminoethyl) ester hydrochloride
  参考文献：
  名称：

  Antagonists of slow-reacting substance of anaphylaxis. 1. Pyrido[2,1-b]quinazolinecarboxylic acid derivatives

  摘要：

  Members of a series of basic amide and ester derivatives of 2-substituted pyrido[2,1-b]quinazoline-8-carboxylic acids were prepared and evaluated for their ability to prevent slow-reacting substance of anaphylaxis (SRS-A) induced contractions of guinea pig ilea. The results indicate that the presence of a branched-chain alkyl group in the 2-position and a sterically demanding substituted aminoethyl carboxylate or carboxamide in the 8-position give optimal in vitro activity. The phenylpiperazine 25 was further found to block SRS-A-related symptomatology after intravenous administration in two animal models.

  DOI：

  10.1021/jm00365a016
• 作为产物：
  描述：

  5-isopropoxy-2-nitro-benzoic acid 在 钯 氮气 、 氢气 作用下， 以 四氢呋喃 为溶剂， 反应 3.5h， 以to yield 816 mg of 5-isopropoxy-2-amino-benzoic acid的产率得到5-异丙氧基-2-氨基-苯甲酸
  参考文献：
  名称：

  Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists

  摘要：

  本发明涉及一般为IP受体拮抗剂的化合物，其由式I表示：其中G1选自a、b1和b2组成的群，A和G2如规范中所定义；或其药学上可接受的盐或溶剂。本发明还涉及含有这种化合物的制药组合物，它们作为治疗剂的使用方法以及其制备方法。

  公开号：

  US06903086B2

文献信息

• [EN] INHIBITORS OF ACETYL-COA CARBOXYLASE<br/>[FR] INHIBITEURS DE L'ACÉTYL-COA CARBOXYLASE
  申请人：FOREST LAB HOLDINGS LTD

  公开号：WO2010127208A1

  公开（公告）日：2010-11-04

  The present invention relates to compounds that act as acetyl-CoA carboxylase (ACC) inhibitors. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.

  本发明涉及作为乙酰辅酶A羧化酶（ACC）抑制剂的化合物。该发明还涉及制备这些化合物的方法、含有这些化合物的组合物，以及使用这些化合物进行治疗的方法。
• Trans-3-(4-oxo-4H-quinazolin-3-yl)-2-propenoic acid derivatives
  申请人：Hoffmann-La Roche Inc.

  公开号：US04281127A1

  公开（公告）日：1981-07-28

  Trans-3-(4-oxo-4H-quinazolin-3-yl)-2-propenoic acid derivatives of the formula ##STR1## wherein R.sub.1 is hydrogen, lower alkyl, lower cycloalkyl, lower alkoxy, hydroxy, halo, lower alkykthio, lower alkylsulfinyl, lower alkylsulfonyl, di-(C.sub.1 -C.sub.7)alkyl-N(CH.sub.2).sub.n O-- or 2-hydroxyethoxy; R.sub.2 is hydrogen, lower alkyl or lower alkoxy; R.sub.3 is hydroxy, lower alkoxy, di-(C.sub.1 -C.sub.7)alkyl-N(CH.sub.2).sub.n O-- or di-(C.sub.1 -C.sub.7)alkyl-N(CH.sub.2).sub.n NH--; and n is 2 to 7; provided that at least one of R.sub.1 and R.sub.2 is other than hydrogen, when R.sub.3 is hydroxy, a salt thereof with a pharmaceutically acceptable base, or when R.sub.3 is di-(C.sub.1 -C.sub.7)alkyl-N(CH.sub.2).sub.n O-- or di-(C.sub.1 -C.sub.7)alkyl-N(CH.sub.2).sub.n NH--, a salt thereof with a pharmaceutically acceptable acid, and a process for the preparation thereof, are described. The compounds of formula I are useful as agents in the prevention of allergic reactions.

  公式为##STR1##的Trans-3-(4-oxo-4H-quinazolin-3-yl)-2-propenoic acid衍生物，其中R.sub.1为氢、较低烷基、较低环烷基、较低烷氧基、羟基、卤素、较低烷硫基、较低烷基磺基、较低烷基砜基、二-(C.sub.1 -C.sub.7)烷基-N(CH.sub.2).sub.n O--或2-羟基乙氧基；R.sub.2为氢、较低烷基或较低烷氧基；R.sub.3为羟基、较低烷氧基、二-(C.sub.1 -C.sub.7)烷基-N(CH.sub.2).sub.n O--或二-(C.sub.1 -C.sub.7)烷基-N(CH.sub.2).sub.n NH--；n为2至7；要求至少R.sub.1和R.sub.2中的一个不是氢，当R.sub.3为羟基时，其与药用可接受的碱的盐，或当R.sub.3为二-(C.sub.1 -C.sub.7)烷基-N(CH.sub.2).sub.n O--或二-(C.sub.1 -C.sub.7)烷基-N(CH.sub.2).sub.n NH--时，其与药用可接受的酸的盐，以及其制备方法。公式I的化合物可用作预防过敏反应的药物。
• Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of
  申请人：Hoffmann-La Roche Inc.

  公开号：US04348396A1

  公开（公告）日：1982-09-07

  Pyrido[2,1-b]quinazolines of the formulas ##STR1## wherein R.sub.1, R.sub.1 ', R.sub.2, R.sub.2 ', R.sub.3, R.sub.3 ', R.sub.4 and R.sub.10 are as hereinafter set forth, and processes for the preparation thereof, are described. The compounds of formulas I and II are useful as agents in the prevention of allergic reactions.

  本文描述了具有以下结构的吡啶并[2,1-b]喹唑啉的化学式##STR1##其中R.sub.1、R.sub.1'、R.sub.2、R.sub.2'、R.sub.3、R.sub.3'、R.sub.4和R.sub.10如下所述，以及其制备方法。化合物I和II的化学式对于预防过敏反应是有用的。
• [EN] QUINAZOLINONE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER<br/>[FR] DÉRIVÉS DE QUINAZOLINONE ET LEURS UTILISATIONS POUR LE TRAITEMENT D'UN CANCER
  申请人：ENYO PHARMA

  公开号：WO2021198188A1

  公开（公告）日：2021-10-07

  The present invention relates to a new class of quinazolinone derivatives of formula (I) and their uses for treating cancer. The invention further relates to pharmaceutical compositions comprising compounds of formula (I). (I)

  本发明涉及一种新的喹唑啉酮衍生物类别，其化学式为（I），以及它们用于治疗癌症的用途。该发明还涉及包含化合物（I）的药物组合物。
• 2-Phenylalkyl-3-aminoalkyl-4(3H)-quinazolinone compound
  申请人：Mitsubishi Chemical Industries Limited

  公开号：US04668682A1

  公开（公告）日：1987-05-26

  Disclosed are a 2-phenylalkyl-3-aminoalkyl-4(3H)-quinazolinone compound of Formula (1): ##STR1## wherein, X represents a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, a phenoxy group, a benzyloxy group, a halogen atom or a hydroxy group; Y represents an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, a benzyloxy group, a halogen atom or a nitro group; R.sup.1 represents a hydrogen atom or an alkyl group having 1 to 5 carbon atoms; R.sup.2 represents an alkyl group having 1 to 5 carbon atoms or a group of Formula (2) ##STR2## [wherein, Z represents a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms or a halogen atom; d is an integer of 1 to 3; and l is an integer of 1 to 5]; or R.sup.1 and R.sup.2 represent together with the nitrogen atom to which they are attached, a cyclic amino group of the formula: ##STR3## [wherein, A represents an alkylene group having 2 to 6 carbon atoms or a group of the formula --(CH.sub.2).sub.2 --O--(CH.sub.2).sub.2 --]; a and b are independently an integer of 1 to 3; and n and m are independently an integer of 1 to 5, or a pharmaceutically acceptable acid addition salt thereof, a process for preparing said compound, a composition comprising said compound as an active ingredient and a method of treatment by use of said compound. The compounds of the present invention have calcium antagonistic, vasodilative, and antihypertensive activities.

  本发明公开了一种具有以下结构的2-苯基烷基-3-氨基烷基-4(3H)-喹唑啉酮化合物（式中，X代表氢原子、具有1到5个碳原子的烷基基团、具有1到5个碳原子的烷氧基团、苯氧基团、苄氧基团、卤素原子或羟基；Y代表具有1到5个碳原子的烷基基团、具有1到5个碳原子的烷氧基团、苄氧基团、卤素原子或硝基基团；R.sup.1代表氢原子或具有1到5个碳原子的烷基基团；R.sup.2代表具有1到5个碳原子的烷基基团或式(2)的基团[式中，Z代表氢原子、具有1到5个碳原子的烷基基团、具有1到5个碳原子的烷氧基团或卤素原子；d为1到3的整数；l为1到5的整数]；或R.sup.1和R.sup.2与它们连接的氮原子一起代表下述结构的环氨基基团：[式中，A代表具有2到6个碳原子的烷基基团或式--(CH.sub.2).sub.2 --O--(CH.sub.2).sub.2 --]；a和b独立地为1到3的整数；n和m独立地为1到5的整数；或其药学上可接受的酸盐，制备该化合物的方法，含有该化合物作为活性成分的组合物以及使用该化合物进行治疗的方法。本发明的化合物具有钙拮抗、扩血管和降压活性。